| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 RBPJL ZNF780B BCL11A ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 SUZ12 ZNF30 ZNF107 ZNF99 ZNF417 NR1I3 ZNF304 ZNF445 | 1.16e-16 | 1459 | 127 | 41 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 RBPJL ZNF780B BCL11A ZNF784 ZBTB24 ZNF829 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 SUZ12 ZNF30 ZNF107 ZNF99 ZNF417 NR1I3 ZNF304 ZNF445 | 1.42e-16 | 1244 | 127 | 38 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 RBPJL ZNF780B BCL11A ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF107 ZNF99 ZNF417 NR1I3 ZNF304 ZNF445 | 2.35e-16 | 1412 | 127 | 40 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 RBPJL ZNF780B BCL11A ZNF784 ZBTB24 ZNF829 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 SUZ12 ZNF30 ZNF107 ZNF99 ZNF417 NR1I3 ZNF304 ZNF445 | 2.86e-16 | 1271 | 127 | 38 | GO:0000987 |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 2.51e-07 | 3 | 127 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 2.49e-06 | 5 | 127 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF493 ZNF268 ZNF175 RBPJL ZNF780B ZNF784 BCL11B ZNF780A ZNF43 ZNF814 ZNF107 ZNF99 NR1I3 ZNF445 | 1.34e-05 | 560 | 127 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF493 ZNF268 ZNF175 RBPJL ZNF780B ZNF784 BCL11B ZNF780A ZNF43 ZNF814 ZNF107 ZNF99 NR1I3 ZNF445 | 1.51e-05 | 566 | 127 | 14 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.03e-03 | 320 | 127 | 8 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.16e-03 | 326 | 127 | 8 | GO:0001217 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 9.16e-06 | 46 | 127 | 5 | GO:0010526 | |
| GeneOntologyBiologicalProcess | retrotransposition | 1.13e-05 | 48 | 127 | 5 | GO:0032197 | |
| GeneOntologyBiologicalProcess | transposition | 1.39e-05 | 50 | 127 | 5 | GO:0032196 | |
| GeneOntologyCellularComponent | multimerin complex | 3.78e-05 | 2 | 129 | 2 | GO:1990972 | |
| GeneOntologyCellularComponent | equatorial microtubule organizing center | 3.73e-04 | 5 | 129 | 2 | GO:0000923 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ARID2 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 SUZ12 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 6.93e-26 | 775 | 126 | 41 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ARID2 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 SUZ12 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 7.66e-26 | 777 | 126 | 41 | PS00028 |
| Domain | zf-C2H2 | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 1.50e-25 | 693 | 126 | 39 | PF00096 |
| Domain | ZnF_C2H2 | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ARID2 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 SUZ12 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 3.44e-25 | 808 | 126 | 41 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 1.92e-24 | 694 | 126 | 38 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ARID2 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 SUZ12 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 2.18e-24 | 796 | 126 | 40 | IPR015880 |
| Domain | Znf_C2H2 | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ARID2 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 3.32e-24 | 805 | 126 | 40 | IPR007087 |
| Domain | - | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 1.05e-23 | 679 | 126 | 37 | 3.30.160.60 |
| Domain | KRAB | ZNF93 ZNF132 ZNF383 ZNF527 ZNF607 ZNF268 ZNF175 ZNF780B ZNF235 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF99 ZNF417 ZNF304 ZNF445 | 2.62e-23 | 358 | 126 | 29 | PS50805 |
| Domain | KRAB | ZNF93 ZNF132 ZNF383 ZNF527 ZNF607 ZNF268 ZNF175 ZNF780B ZNF235 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF99 ZNF417 ZNF304 ZNF445 | 2.62e-23 | 358 | 126 | 29 | PF01352 |
| Domain | KRAB | ZNF93 ZNF132 ZNF383 ZNF527 ZNF607 ZNF268 ZNF175 ZNF780B ZNF235 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF99 ZNF417 ZNF304 ZNF445 | 6.16e-23 | 369 | 126 | 29 | SM00349 |
| Domain | KRAB | ZNF93 ZNF132 ZNF383 ZNF527 ZNF607 ZNF268 ZNF175 ZNF780B ZNF235 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 ZNF30 ZNF99 ZNF417 ZNF304 ZNF445 | 6.65e-23 | 370 | 126 | 29 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF502 ZNF93 ZNF527 ZNF672 ZNF493 ZNF607 ZNF423 ZNF780B ZBTB24 ZNF773 ZNF792 ZNF780A ZNF43 ZNF587 ZNF256 ZNF814 ZNF30 ZNF107 ZNF99 ZNF417 ZNF445 | 2.45e-15 | 314 | 126 | 21 | PF13912 |
| Domain | PHOSPHORYLASE | 3.00e-07 | 3 | 126 | 3 | PS00102 | |
| Domain | Phosphorylase | 3.00e-07 | 3 | 126 | 3 | PF00343 | |
| Domain | Glycg_phsphrylas | 3.00e-07 | 3 | 126 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 3.00e-07 | 3 | 126 | 3 | IPR000811 | |
| Domain | Serpin_CS | 6.13e-05 | 32 | 126 | 4 | IPR023795 | |
| Domain | Serpin_dom | 9.84e-05 | 36 | 126 | 4 | IPR023796 | |
| Domain | zf-H2C2_2 | 1.03e-04 | 14 | 126 | 3 | PF13465 | |
| Domain | SERPIN | 1.10e-04 | 37 | 126 | 4 | SM00093 | |
| Domain | SERPIN | 1.10e-04 | 37 | 126 | 4 | PS00284 | |
| Domain | Serpin | 1.22e-04 | 38 | 126 | 4 | PF00079 | |
| Domain | Serpin_fam | 1.35e-04 | 39 | 126 | 4 | IPR000215 | |
| Domain | GCP | 4.46e-04 | 5 | 126 | 2 | IPR007259 | |
| Domain | Spc97_Spc98 | 4.46e-04 | 5 | 126 | 2 | PF04130 | |
| Domain | Anoct_dimer | 9.27e-04 | 7 | 126 | 2 | PF16178 | |
| Domain | Anoct_dimer | 9.27e-04 | 7 | 126 | 2 | IPR032394 | |
| Domain | Anoctamin | 1.96e-03 | 10 | 126 | 2 | PF04547 | |
| Domain | Anoctamin | 1.96e-03 | 10 | 126 | 2 | IPR007632 | |
| Domain | EMI | 1.96e-03 | 10 | 126 | 2 | PF07546 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF383 ZNF493 GAMT ZNF607 ZNF678 ZNF268 ZNF175 INTS1 ZNF235 ZNF599 ZNF19 ZNF773 ZNF713 ZNF37A ZNF792 ZNF43 ARID2 ZNF587 ZNF256 ZFP1 ZNF264 SUZ12 ZNF30 ZNF99 ZNF417 NR1I3 ZNF304 ZNF445 | 5.33e-07 | 1387 | 104 | 28 | M734 |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 3.17e-05 | 9 | 104 | 3 | M47621 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 1.34e-04 | 14 | 104 | 3 | M19193 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF93 ZNF383 ZNF493 ZNF268 ZNF780B ZNF235 ZNF773 ZNF780A ZNF43 ZFP1 ZNF814 SUZ12 ZNF107 ZNF99 NR1I3 ZNF445 | 1.52e-04 | 768 | 104 | 16 | MM14851 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF93 ZNF383 IPO8 ZNF493 ZNF268 ZNF780B INTS1 ZNF235 ZNF773 ZNF780A ZNF43 ZFP1 ZNF814 SUZ12 ZNF107 ZNF99 NUP160 NR1I3 ZNF445 | 1.54e-04 | 1022 | 104 | 19 | MM15436 |
| Pubmed | ZNF93 ZNF383 ZNF493 ZNF607 ZNF678 ZNF235 ZNF792 ZNF780A ZNF587 ZFP1 ZNF264 ZNF107 ZNF417 ZNF445 | 8.31e-15 | 181 | 130 | 14 | 37372979 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 6.53e-10 | 49 | 130 | 7 | 9630514 | |
| Pubmed | 1.97e-09 | 15 | 130 | 5 | 15885501 | ||
| Pubmed | Functional analysis of the SRY-KRAB interaction in mouse sex determination. | 3.85e-08 | 10 | 130 | 4 | 18588511 | |
| Pubmed | 6.03e-08 | 11 | 130 | 4 | 15203215 | ||
| Pubmed | Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. | 6.03e-08 | 11 | 130 | 4 | 15469996 | |
| Pubmed | 7.46e-08 | 29 | 130 | 5 | 14563677 | ||
| Pubmed | Multiple genes encoding zinc finger domains are expressed in human T cells. | 1.06e-07 | 31 | 130 | 5 | 2288909 | |
| Pubmed | 1.30e-07 | 13 | 130 | 4 | 19850934 | ||
| Pubmed | 3.28e-07 | 16 | 130 | 4 | 8467795 | ||
| Pubmed | 7.24e-07 | 83 | 130 | 6 | 20562864 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15203214 | ||
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 1.39e-05 | 2 | 130 | 2 | 23354406 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22406480 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 1.39e-05 | 2 | 130 | 2 | 27668655 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12196208 | ||
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 1.39e-05 | 2 | 130 | 2 | 15504361 | |
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 1.39e-05 | 2 | 130 | 2 | 12702576 | |
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 1.39e-05 | 2 | 130 | 2 | 28935635 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 1.39e-05 | 2 | 130 | 2 | 35022507 | |
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 1.39e-05 | 2 | 130 | 2 | 21403642 | |
| Pubmed | The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. | 1.39e-05 | 2 | 130 | 2 | 11719382 | |
| Pubmed | CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. | 1.39e-05 | 2 | 130 | 2 | 15465497 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25111616 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 11267667 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 29491058 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25130497 | ||
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 1.39e-05 | 2 | 130 | 2 | 23168150 | |
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 1.39e-05 | 2 | 130 | 2 | 11863458 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 1.39e-05 | 2 | 130 | 2 | 22808225 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 1.39e-05 | 2 | 130 | 2 | 14970861 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 10653592 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 29112685 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 10956412 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 20428762 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35874657 | ||
| Pubmed | 1.80e-05 | 14 | 130 | 3 | 19833888 | ||
| Pubmed | 2.05e-05 | 43 | 130 | 4 | 24172014 | ||
| Pubmed | 2.25e-05 | 15 | 130 | 3 | 2575583 | ||
| Pubmed | Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. | 4.15e-05 | 3 | 130 | 2 | 19070595 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 9828132 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 22451727 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 7724531 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 24898082 | ||
| Pubmed | A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. | 4.15e-05 | 3 | 130 | 2 | 21126757 | |
| Pubmed | Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). | 4.15e-05 | 3 | 130 | 2 | 24635038 | |
| Pubmed | Heparin enhances serpin inhibition of the cysteine protease cathepsin L. | 4.15e-05 | 3 | 130 | 2 | 19959474 | |
| Pubmed | Uteroglobin suppresses SCCA gene expression associated with allergic asthma. | 4.15e-05 | 3 | 130 | 2 | 15677460 | |
| Pubmed | Regulation of pulmonary fibrosis by chemokine receptor CXCR3. | 4.15e-05 | 3 | 130 | 2 | 15254596 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF502 IPO5 IPO8 WFS1 CIP2A INTS1 PEX13 TBC1D24 ZNF773 TBC1D4 UTP4 RBAK ZNF417 NUP160 ABHD16A | 4.58e-05 | 1203 | 130 | 15 | 29180619 |
| Pubmed | ZNF93 ZNF175 ZNF423 ZNF235 ZBTB24 ZNF773 ZNF43 ARID2 ZMIZ2 RBAK ZNF99 ZNF445 | 5.38e-05 | 808 | 130 | 12 | 20412781 | |
| Pubmed | Requirement for phosphatidylinositol transfer protein in epidermal growth factor signaling. | 8.28e-05 | 4 | 130 | 2 | 7761838 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 35766181 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 16549498 | ||
| Pubmed | Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. | 8.28e-05 | 4 | 130 | 2 | 12949073 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 21576355 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 10744719 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 12739008 | ||
| Pubmed | 8.56e-05 | 23 | 130 | 3 | 19720844 | ||
| Pubmed | 1.01e-04 | 284 | 130 | 7 | 15057824 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.01e-04 | 608 | 130 | 10 | 36089195 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | IPO5 IPO8 POC1A TUBGCP4 TUBGCP5 SERPINB12 ARID2 RBAK ZFP1 FAM83D PYGM GNAO1 NUP160 NSMCE4A | 1.12e-04 | 1155 | 130 | 14 | 20360068 |
| Pubmed | Analysis of a lung defect in autophagy-deficient mouse strains. | 1.25e-04 | 26 | 130 | 3 | 24275123 | |
| Pubmed | GCP5 and GCP6: two new members of the human gamma-tubulin complex. | 1.38e-04 | 5 | 130 | 2 | 11694571 | |
| Pubmed | 1.40e-04 | 513 | 130 | 9 | 25798074 | ||
| Pubmed | Characterising the dynamics of placental glycogen stores in the mouse. | 1.74e-04 | 29 | 130 | 3 | 32798765 | |
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 14996434 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 23644491 | ||
| Pubmed | Identification and characterization of TMEM16E and TMEM16F genes in silico. | 2.06e-04 | 6 | 130 | 2 | 15067359 | |
| Pubmed | 2.88e-04 | 7 | 130 | 2 | 11682607 | ||
| Pubmed | Strict in vivo specificity of the Bcl11a erythroid enhancer. | 2.88e-04 | 7 | 130 | 2 | 27707736 | |
| Pubmed | Developmental expression and biochemical characterization of Emu family members. | 2.88e-04 | 7 | 130 | 2 | 12221002 | |
| Pubmed | UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair. | 3.01e-04 | 155 | 130 | 5 | 34921745 | |
| Pubmed | 3.83e-04 | 8 | 130 | 2 | 2023909 | ||
| Pubmed | 3.83e-04 | 8 | 130 | 2 | 19557197 | ||
| Pubmed | 3.83e-04 | 8 | 130 | 2 | 27114554 | ||
| Pubmed | 3.83e-04 | 8 | 130 | 2 | 35090564 | ||
| Pubmed | 4.90e-04 | 41 | 130 | 3 | 20889853 | ||
| Pubmed | 4.91e-04 | 9 | 130 | 2 | 25972180 | ||
| Pubmed | 4.91e-04 | 9 | 130 | 2 | 11956313 | ||
| Pubmed | 4.91e-04 | 9 | 130 | 2 | 8838651 | ||
| Pubmed | Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypes. | 4.91e-04 | 9 | 130 | 2 | 18714373 | |
| Pubmed | 4.91e-04 | 9 | 130 | 2 | 28935710 | ||
| Pubmed | 5.54e-04 | 493 | 130 | 8 | 15368895 | ||
| Pubmed | 6.12e-04 | 10 | 130 | 2 | 24124161 | ||
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 6.12e-04 | 10 | 130 | 2 | 19015192 | |
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 6.12e-04 | 10 | 130 | 2 | 23532839 | |
| Pubmed | 6.12e-04 | 10 | 130 | 2 | 21768215 | ||
| Pubmed | CDK5RAP2 stimulates microtubule nucleation by the gamma-tubulin ring complex. | 6.12e-04 | 10 | 130 | 2 | 21135143 | |
| Pubmed | BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. | 6.12e-04 | 10 | 130 | 2 | 16091750 | |
| Pubmed | 6.12e-04 | 10 | 130 | 2 | 24692353 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZNF268 ZNF175 RBPJL ZBTB24 ZNF19 BCL11B ZNF37A ZNF43 RBAK ZNF30 NR1I3 | 6.27e-04 | 908 | 130 | 11 | 19274049 |
| Pubmed | 7.46e-04 | 11 | 130 | 2 | 29263092 | ||
| Pubmed | 7.46e-04 | 11 | 130 | 2 | 19670153 | ||
| Pubmed | Cell Type-Specific Role of RNA Nuclease SMG6 in Neurogenesis. | 7.46e-04 | 11 | 130 | 2 | 34943873 | |
| Pubmed | 8.93e-04 | 12 | 130 | 2 | 17632510 | ||
| Pubmed | 9.66e-04 | 116 | 130 | 4 | 21549307 | ||
| Pubmed | 1.05e-03 | 13 | 130 | 2 | 12376551 | ||
| Pubmed | Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse. | 1.05e-03 | 13 | 130 | 2 | 12696059 | |
| Pubmed | 1.05e-03 | 13 | 130 | 2 | 11863365 | ||
| Interaction | TRIM28 interactions | IPO5 ZNF93 ZNF383 ZNF527 IPO8 ZNF493 ZNF607 ZNF678 ZNF268 ZNF235 ZNF829 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF587 UTP4 RBAK ZNF256 ZFP1 ZNF264 SUZ12 ZNF30 ZNF107 ZNF417 NUP160 ZNF304 ZNF445 | 1.71e-09 | 1474 | 127 | 31 | int:TRIM28 |
| Interaction | LTBP2 interactions | 1.10e-06 | 85 | 127 | 7 | int:LTBP2 | |
| Interaction | TRIM41 interactions | ZNF784 ZBTB24 ZNF773 ZNF792 ZNF780A ZNF587 RBAK ZFP1 ZNF264 ZNF417 | 1.52e-06 | 223 | 127 | 10 | int:TRIM41 |
| Interaction | TSGA10 interactions | 3.44e-05 | 97 | 127 | 6 | int:TSGA10 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF132 ZNF383 ZNF527 ZNF607 ZNF175 ZNF780B ZNF235 ZNF784 ZNF829 ZNF599 ZNF773 ZNF792 ZNF780A ZNF587 ZNF256 ZNF814 ZNF264 ZNF30 ZNF417 ZNF304 | 1.86e-10 | 1192 | 130 | 20 | chr19q13 |
| Cytoband | 18q21.3 | 3.60e-06 | 11 | 130 | 3 | 18q21.3 | |
| Cytoband | 19q13.43 | 5.17e-06 | 87 | 130 | 5 | 19q13.43 | |
| Cytoband | 19q13.4 | 7.82e-05 | 79 | 130 | 4 | 19q13.4 | |
| Cytoband | 19q13.11 | 2.89e-04 | 45 | 130 | 3 | 19q13.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 4.16e-04 | 122 | 130 | 4 | chr19p12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF502 ZNF93 ZNF132 ZNF383 ZNF527 ZNF672 ZNF493 ZNF607 ZNF678 ZNF268 ZNF175 ZNF423 ZNF780B BCL11A ZNF235 ZNF784 ZBTB24 ZNF829 ZNF599 ZNF19 ZNF773 ZNF713 BCL11B ZNF37A ZNF792 ZNF780A ZNF43 ZNF587 RBAK ZNF256 ZFP1 ZNF814 ZNF264 SUZ12 ZNF30 ZNF107 ZNF99 ZNF417 ZNF304 ZNF445 | 1.76e-30 | 718 | 98 | 40 | 28 |
| GeneFamily | Glycogen phosphorylases | 1.54e-07 | 3 | 98 | 3 | 437 | |
| GeneFamily | Serpin peptidase inhibitors | 4.67e-05 | 37 | 98 | 4 | 739 | |
| GeneFamily | EMI domain containing | 6.00e-04 | 7 | 98 | 2 | 540 | |
| GeneFamily | Anoctamins | 1.27e-03 | 10 | 98 | 2 | 865 | |
| GeneFamily | Armadillo repeat containing|Importins | 4.20e-03 | 18 | 98 | 2 | 596 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | IPO5 INTS1 NDST2 SIDT1 PEX13 BCL11A TUBGCP4 MMRN1 ZNF713 TBC1D4 HIBCH PI4KA SYNE2 PITPNA ZNF814 PYGB TMEM131 TOR1B SUZ12 NUP160 | 1.82e-06 | 1215 | 128 | 20 | M41122 |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-07 | 157 | 130 | 7 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-06 | 189 | 130 | 7 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 5.91e-06 | 153 | 130 | 6 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | Adult-Immune-mast_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.36e-06 | 159 | 130 | 6 | 9f53fe2e0f25448d62a591c8e528e9a49b5400d5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-05 | 178 | 130 | 6 | f94e306b9550f3d1b5de0bb806790c17823d439e | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.49e-05 | 180 | 130 | 6 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.49e-05 | 180 | 130 | 6 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-05 | 185 | 130 | 6 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-05 | 186 | 130 | 6 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-05 | 194 | 130 | 6 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-05 | 194 | 130 | 6 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.70e-05 | 200 | 130 | 6 | ef42753c9fbe3770e3f415cd7ab412654d359edb | |
| Drug | vinylene | ZNF93 ZNF132 ZNF175 ZNF423 ZNF235 ZBTB24 BCL11B ARID2 RBAK ZNF264 ZNF107 ZNF304 ZNF445 | 1.47e-09 | 245 | 129 | 13 | CID000006326 |
| Drug | 5-n-propylthioadenosine | 1.46e-08 | 6 | 129 | 4 | CID000656428 | |
| Drug | 3,5-dimethylphenyl isocyanate | 1.78e-07 | 3 | 129 | 3 | CID000521488 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 1.78e-07 | 3 | 129 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 1.78e-07 | 3 | 129 | 3 | CID000191554 | |
| Drug | hydan | 1.78e-07 | 3 | 129 | 3 | CID000008360 | |
| Drug | EHMF | 1.78e-07 | 3 | 129 | 3 | CID000033931 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 1.78e-07 | 3 | 129 | 3 | CID000147839 | |
| Drug | pyridoxal 5'-methylenephosphonate | 1.78e-07 | 3 | 129 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 1.78e-07 | 3 | 129 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 1.78e-07 | 3 | 129 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 1.78e-07 | 3 | 129 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 1.78e-07 | 3 | 129 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 1.78e-07 | 3 | 129 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 1.78e-07 | 3 | 129 | 3 | CID000446801 | |
| Drug | NSC758405 | 1.78e-07 | 3 | 129 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 1.78e-07 | 3 | 129 | 3 | CID000151920 | |
| Drug | riboflavin tetraacetate | 1.78e-07 | 3 | 129 | 3 | CID000094186 | |
| Drug | pyridoxal phosphoglucose | 1.78e-07 | 3 | 129 | 3 | CID000196007 | |
| Drug | 2,5-dimethyl-3-furanone | 1.78e-07 | 3 | 129 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 1.78e-07 | 3 | 129 | 3 | CID000011459 | |
| Drug | galocitabine | 7.08e-07 | 4 | 129 | 3 | CID000065950 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 7.08e-07 | 4 | 129 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 7.08e-07 | 4 | 129 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 7.08e-07 | 4 | 129 | 3 | CID000094262 | |
| Drug | Mem-CC | 7.08e-07 | 4 | 129 | 3 | CID003081269 | |
| Drug | 5-deoxyribose-1-phosphate | 7.08e-07 | 4 | 129 | 3 | CID000135786 | |
| Drug | ingliforib | 7.08e-07 | 4 | 129 | 3 | CID006451325 | |
| Drug | uric acid riboside | 7.08e-07 | 4 | 129 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 7.08e-07 | 4 | 129 | 3 | CID000125259 | |
| Drug | BCIp4A | 7.08e-07 | 4 | 129 | 3 | CID000192417 | |
| Drug | pyridoxal diphosphate | 7.08e-07 | 4 | 129 | 3 | CID000125696 | |
| Drug | 3'-chloromethotrexate | 7.08e-07 | 4 | 129 | 3 | CID000097703 | |
| Drug | heptulose-2-P | 1.76e-06 | 5 | 129 | 3 | CID000124823 | |
| Drug | m-anisidine | 1.76e-06 | 5 | 129 | 3 | CID000010824 | |
| Drug | 6-FPLP | 1.76e-06 | 5 | 129 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 1.76e-06 | 5 | 129 | 3 | CID009576855 | |
| Drug | 2-hydroxypropylphosphonate | 1.76e-06 | 5 | 129 | 3 | CID000441028 | |
| Drug | DHPBU | 1.76e-06 | 5 | 129 | 3 | CID000125914 | |
| Drug | 6-FDPL | 1.76e-06 | 5 | 129 | 3 | CID000129578 | |
| Drug | 5'-isobutylthioinosine | 1.76e-06 | 5 | 129 | 3 | CID003080910 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 1.76e-06 | 5 | 129 | 3 | CID003082179 | |
| Drug | GlcMan | 1.76e-06 | 5 | 129 | 3 | CID000152120 | |
| Drug | U66985 | 1.76e-06 | 5 | 129 | 3 | CID000127224 | |
| Drug | indirubin-5-sulphonate | 1.76e-06 | 5 | 129 | 3 | CID005288641 | |
| Drug | AC1O3M08 | 1.76e-06 | 5 | 129 | 3 | CID006331955 | |
| Drug | AC1LCUXJ | 1.76e-06 | 5 | 129 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 1.76e-06 | 5 | 129 | 3 | CID000080578 | |
| Drug | etafenone | 1.76e-06 | 5 | 129 | 3 | CID000003275 | |
| Drug | ddEtUrd | 1.76e-06 | 5 | 129 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 1.76e-06 | 5 | 129 | 3 | CID000125618 | |
| Drug | CV-araU | 3.51e-06 | 6 | 129 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 3.51e-06 | 6 | 129 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 3.51e-06 | 6 | 129 | 3 | CID006438602 | |
| Drug | DNPP | 3.51e-06 | 6 | 129 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 3.51e-06 | 6 | 129 | 3 | CID000082693 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 3.51e-06 | 6 | 129 | 3 | CID000152984 | |
| Drug | EdUMP | 3.51e-06 | 6 | 129 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 3.51e-06 | 6 | 129 | 3 | CID000126430 | |
| Drug | NSC-97433 | 3.51e-06 | 6 | 129 | 3 | CID000001803 | |
| Drug | AzddCyd | 3.51e-06 | 6 | 129 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 3.51e-06 | 6 | 129 | 3 | CID000065561 | |
| Drug | AR-L57 | 3.51e-06 | 6 | 129 | 3 | CID000156890 | |
| Drug | Carbocyclic Ivdu | 3.51e-06 | 6 | 129 | 3 | CID006439191 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 6.12e-06 | 7 | 129 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 6.12e-06 | 7 | 129 | 3 | CID003080803 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 6.12e-06 | 7 | 129 | 3 | CID000356019 | |
| Drug | heptenitol | 6.12e-06 | 7 | 129 | 3 | CID000188267 | |
| Drug | AC1L3372 | 6.12e-06 | 7 | 129 | 3 | CID000108025 | |
| Drug | 1 Gpt | 6.12e-06 | 7 | 129 | 3 | CID000101247 | |
| Drug | formycins | 6.12e-06 | 7 | 129 | 3 | CID000512867 | |
| Drug | Promonta | 6.12e-06 | 7 | 129 | 3 | CID000108494 | |
| Drug | 5'-methylthioinosine | 6.12e-06 | 7 | 129 | 3 | CID000161214 | |
| Drug | hydantocidin | 6.12e-06 | 7 | 129 | 3 | CID000125429 | |
| Drug | BrVarafUTP | 9.57e-06 | 24 | 129 | 4 | CID005273539 | |
| Drug | AC1NUVX5 | 9.75e-06 | 8 | 129 | 3 | CID005461894 | |
| Drug | 6-methylpurine | 9.75e-06 | 8 | 129 | 3 | CID005287547 | |
| Drug | amorphin | 9.75e-06 | 8 | 129 | 3 | CID000122792 | |
| Drug | Etafenone [inn] | 9.75e-06 | 8 | 129 | 3 | CID000066659 | |
| Drug | 6-benzyl-2-thiouracil | 1.46e-05 | 9 | 129 | 3 | CID000685814 | |
| Drug | 5'-methylthiotubercidin | 1.46e-05 | 9 | 129 | 3 | CID000188350 | |
| Drug | alpha-maltosyl fluoride | 1.46e-05 | 9 | 129 | 3 | CID000194237 | |
| Drug | 5-Iodoribose 1-phosphate | 1.46e-05 | 9 | 129 | 3 | CID003035973 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 1.46e-05 | 9 | 129 | 3 | CID000107502 | |
| Drug | 8-azidoadenosine 5'-monophosphate | 2.07e-05 | 10 | 129 | 3 | CID000124726 | |
| Drug | 2,6-dihydroxypyridine | 2.07e-05 | 10 | 129 | 3 | CID000069371 | |
| Drug | 6-methyluridine | 2.07e-05 | 10 | 129 | 3 | CID000092887 | |
| Drug | UDP-pyridoxal | 2.07e-05 | 10 | 129 | 3 | CID000126789 | |
| Drug | glucosyl fluoride | 2.84e-05 | 11 | 129 | 3 | CID000150967 | |
| Drug | Cid 11299980 | 2.84e-05 | 11 | 129 | 3 | CID009856533 | |
| Drug | 9 Da | 2.84e-05 | 11 | 129 | 3 | CID005287565 | |
| Drug | 5-(2-chloroethyl)uracil | 3.19e-05 | 2 | 129 | 2 | CID010442204 | |
| Drug | 6878P | 3.19e-05 | 2 | 129 | 2 | CID002725013 | |
| Drug | 1-N-Acetyl-Beta-D-Glucosamine | 3.19e-05 | 2 | 129 | 2 | DB02320 | |
| Drug | AC1LBRFU | 3.19e-05 | 2 | 129 | 2 | CID000562981 | |
| Drug | BCX-34 | 3.77e-05 | 12 | 129 | 3 | CID000060817 | |
| Drug | Ap4U | 3.77e-05 | 12 | 129 | 3 | CID000165888 | |
| Drug | phenylurethane | 3.77e-05 | 12 | 129 | 3 | CID000007591 | |
| Drug | acyclothymidine | 3.77e-05 | 12 | 129 | 3 | CID000072358 | |
| Drug | 5'-deoxypyridoxal | 3.77e-05 | 12 | 129 | 3 | CID000164889 | |
| Disease | nonsyndromic deafness (is_implicated_in) | 1.78e-05 | 2 | 125 | 2 | DOID:0050563 (is_implicated_in) | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.02e-04 | 27 | 125 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Abnormality of the skeletal system | 4.90e-04 | 8 | 125 | 2 | C4021790 | |
| Disease | Ciliopathies | 1.25e-03 | 110 | 125 | 4 | C4277690 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 1.80e-03 | 15 | 125 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | IGA glomerulonephritis | 1.93e-03 | 58 | 125 | 3 | EFO_0004194 | |
| Disease | Cannabis use | 2.05e-03 | 16 | 125 | 2 | EFO_0007585 | |
| Disease | Disorder of eye | 2.13e-03 | 212 | 125 | 5 | C0015397 | |
| Disease | sphingomyelin 14:0 measurement | 2.32e-03 | 17 | 125 | 2 | EFO_0010390 | |
| Disease | cortical thickness | ZNF423 SIDT1 ARHGEF12 RAB44 THADA BCL11B PI4KA UTP4 PKHD1 PYGB TMEM131 SMG6 | 2.76e-03 | 1113 | 125 | 12 | EFO_0004840 |
| Disease | non-word reading | 2.92e-03 | 67 | 125 | 3 | EFO_0005299 | |
| Disease | diabetes mellitus | 3.04e-03 | 68 | 125 | 3 | EFO_0000400 | |
| Disease | Takayasu arteritis | 3.68e-03 | 148 | 125 | 4 | EFO_1001857 | |
| Disease | hematocrit | ZNF383 BCL11A ZNF829 BCL11B TBC1D4 ARID2 ZMIZ2 BEND7 PKHD1 GNAO1 NUP160 | 3.86e-03 | 1011 | 125 | 11 | EFO_0004348 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SDLNKRFILSFLHAH | 886 | Q86US8 | |
| SFFVHNVATERLHLK | 516 | A0FGR9 | |
| FLQSLIKFFHAQHNF | 211 | Q8TDY4 | |
| QGLKIHQRFHFASAL | 616 | Q9HD20 | |
| QLALFLARKHLHNFE | 526 | O95870 | |
| QRQRFSFITHLQDKH | 1676 | Q68CP9 | |
| QRIHHFIIHNKETFF | 241 | Q32M45 | |
| FAKHQARAHLFQTSK | 1111 | Q9C0F0 | |
| FHLNLTLNTDFVSKH | 96 | Q9UKP5 | |
| HQFFLDRSAHLKVSV | 426 | Q9NZN5 | |
| ARIHHFIINNKDTFF | 286 | Q9BYT9 | |
| SIHQEFTRTNFHLFI | 501 | Q9UBG7 | |
| KTSFLHLLHQNSFAT | 846 | Q7Z6P3 | |
| NFIHKQERRLFTNFH | 211 | Q00169 | |
| SRFNAFKRTNTILHH | 11 | Q6NVY1 | |
| LKLSFHGFNTINHFF | 166 | Q8NGK9 | |
| LFHFHGTLRKLQLQE | 246 | Q14994 | |
| KDFFTNHTLVLHVAR | 191 | Q9UM07 | |
| ATHRQKFLFSLSQHI | 131 | Q8NBT0 | |
| ASFHVRKKTHIQLQF | 2731 | Q5T1H1 | |
| HFVHVAEKLLQLQNF | 226 | Q7LDG7 | |
| HLAAFINKFVQFIHK | 1951 | Q8N201 | |
| IHLSINFFSLNKTLH | 911 | Q13201 | |
| QRSLEQHQRLFHSLF | 741 | Q9H8L6 | |
| FKFQSNLVVHRRSHT | 386 | Q9H165 | |
| FLRNHKQEKHLVFFS | 261 | Q8NHQ9 | |
| RFLNSPLFHAKHQNT | 86 | A0A1B0GTH6 | |
| LLSHFQSSNKFDHLT | 301 | Q9H4H8 | |
| AVLFSHRKIQFHIFT | 131 | A0PJZ3 | |
| RHAQFLLVNFNHIHK | 966 | P42356 | |
| HDHFLSNLLAQSFIL | 561 | Q9UGJ1 | |
| SNFRFHRFLDVNSHK | 46 | Q96RT8 | |
| NQSFHFRIHRQLKNV | 61 | P0C869 | |
| RFHHVAQAFLKLLSS | 116 | Q6ZUF6 | |
| ILANEHNVALFKHFA | 201 | O00410 | |
| NRFFTLTVIRHHLAF | 611 | Q9H094 | |
| QQRKFSHSTLRHFGL | 176 | Q7Z449 | |
| STFLHILAKSLSQHF | 1061 | A4D2P6 | |
| FKFQSNLIVHRRSHT | 436 | Q9C0K0 | |
| LRKKNSQVTFLHVFH | 136 | A1L3X0 | |
| VHFFHTNFLVSQLIR | 811 | Q86TI2 | |
| VLFLTRHFIFHDNNN | 306 | Q8J025 | |
| QNLTRHFKESIKFIH | 61 | Q9NRW4 | |
| THQFNFIKNHAFRLL | 146 | Q14353 | |
| DRSFLNLFHLVHAQA | 421 | Q5MNV8 | |
| LSQTSQDFKHHSFLI | 471 | Q8N7W2 | |
| NLFQKNSSFHPIRVH | 431 | Q8IYX8 | |
| ENFHHIFATLSRLKI | 731 | Q9NV70 | |
| LLSHIFHGRKNFFIT | 461 | O95479 | |
| FSRHLIFQLHDVAFK | 166 | Q96LW4 | |
| LHAFSSLKFHNELNL | 481 | O15397 | |
| KLASHHNHFSQIVIF | 186 | Q6IF99 | |
| LQEFVKATQIRFHFH | 476 | O75445 | |
| SKKRQLLLFQFAHHL | 341 | Q969X6 | |
| FKQHLLQSRHRGAFE | 1096 | Q6YHU6 | |
| NLFELHIHQAFLTSA | 626 | Q96KN7 | |
| RFEHHSNILLTFENK | 436 | Q8WXH0 | |
| NFFTTLRVVHHKFHS | 321 | Q9BXJ8 | |
| HLEHNQFSKLNLALF | 211 | Q86VH5 | |
| QFDKHASLRHSLFNT | 256 | Q5HYW2 | |
| DHTKFSFNLENHIIL | 41 | Q96DL1 | |
| FIQKHGTNFLKDHRF | 326 | Q13393 | |
| IFQASKHHLIKLSFQ | 461 | Q7RTZ1 | |
| VETHFTFKNLHFRLF | 186 | P09471 | |
| VFKHLNNFLQGKRFH | 626 | Q53H47 | |
| NSNIPLETRHFLFKH | 251 | Q9UKZ4 | |
| ENTFNKTHTFHFLLG | 206 | Q9NXX6 | |
| VLDVANHFSRLKIHF | 161 | Q92968 | |
| NHFSRLKIHFTKVFS | 166 | Q92968 | |
| FQVLGQAFHKHLSSL | 2206 | P08F94 | |
| FFQEVARKHIISHLF | 826 | Q12769 | |
| VHHQFQKLLTEFNKS | 81 | P29508 | |
| TNLTHLYLHNNKFTF | 191 | P23515 | |
| NHPFLFFIRHNKTQT | 381 | Q96P63 | |
| TVLLHFHFRKQSDSL | 266 | Q8IZF4 | |
| LFHSALLHFQEVRTK | 176 | Q8NBQ7 | |
| FHARNIHQTFQLIFN | 226 | Q8TCG1 | |
| FFSEKLVLHLQQRTH | 251 | P17032 | |
| SKRQFVHLAVHAENF | 326 | Q9ULP9 | |
| KAFRLSSFLHAHQRI | 351 | P17039 | |
| TFAQKFELTTHQRIH | 276 | Q6P2D0 | |
| KTFNHKLTFVHHQRI | 326 | P52740 | |
| AFNQFSTLITHKKIH | 181 | P35789 | |
| AFNHFSALRKHQIIH | 321 | A8MXY4 | |
| AFSNFSALRKHEIIH | 461 | A8MXY4 | |
| AFNHFSALRKHQIIH | 601 | A8MXY4 | |
| VFNQFSTLTRHKIIH | 336 | Q9UII5 | |
| DKVHFFNSFFHRQLV | 601 | Q96HI0 | |
| KAFTHRSTFIQHNVT | 346 | Q96NL3 | |
| FNKFSNLTQHKRIHT | 246 | Q5SXM1 | |
| AFTQFASLTRHKRIH | 301 | Q5SXM1 | |
| FNKFSSLTQHRRIHT | 386 | Q5SXM1 | |
| FTKSSQLFQHARIHT | 291 | Q8NA42 | |
| AFSFKSQLIIHQRIH | 536 | Q14587 | |
| QAFNFHTKLTRHQRI | 336 | P17023 | |
| FNHVRFLQRLNSTHL | 116 | Q9NTN9 | |
| TELKKNFNRHLHFTL | 26 | P11217 | |
| NFNRHLHFTLVKDRN | 31 | P11217 | |
| FNLNSAFIRHRKVHT | 466 | Q9NYW8 | |
| LKHFQLRTNVAFHFT | 166 | Q9NXL6 | |
| HLQLTFTGFFHKNDK | 156 | Q15022 | |
| FRQKFCFINHQRVHT | 361 | Q96SQ5 | |
| FFTFNSNLLKHQNVH | 611 | Q9Y2P7 | |
| TFRQSALLFHQARAH | 136 | Q499Z4 | |
| SHFHASFFQNRKILP | 151 | Q92545 | |
| FRQKFCFINHQRVHT | 361 | Q8TAU3 | |
| SFRLNSSLKIHQNIH | 401 | Q96SK3 | |
| SFRFISVLKAHQNIH | 541 | Q96SK3 | |
| SFNRHLHFTLVKDRN | 31 | P11216 | |
| FFRAHEHSLLSAQLK | 171 | P52849 | |
| SFLKQEGRHLHALAF | 91 | P55017 | |
| VHHQFQKLLTEFNKS | 81 | P48594 | |
| AFRLHIQFTRHQKFH | 201 | O75290 | |
| AFQLHIQLTRHQKFH | 201 | Q9Y6R6 | |
| KKLQHLFAFLAHTQR | 486 | Q8NB14 | |
| VFIFEHKAQHISRFI | 116 | O60343 | |
| AFTKSSQLFLHLRIH | 276 | Q3KNS6 | |
| FRLQHNLAVSNHVFQ | 436 | Q8NF64 | |
| FNQFSNLTTHKRIHT | 351 | P17038 | |
| KVFKYNHFLAIHQRS | 301 | O43167 | |
| KLFSHKSNLFIHQIV | 226 | Q6PK81 | |
| NFVLHNRRHTGEKSF | 301 | O43296 | |
| TFNKSSQLISHKRFH | 986 | P59923 | |
| KFFRHSSVLFRHQKL | 526 | Q8TBZ5 | |
| FFSRSSNLIQHKRVH | 346 | Q3KQV3 | |
| FYRFSNLNTHKIIHT | 566 | Q6ZR52 | |
| HQVLYRHFIQSLSKF | 201 | Q6PGP7 | |
| AFSRKDTLVQHQRFH | 371 | Q9HCX3 | |
| KAFRQHSSFTQHLRI | 321 | Q8N859 | |
| FSNFESFQTHLKLHL | 641 | Q2M1K9 | |
| SFNRHLHFTLVKDRN | 31 | P06737 | |
| KCFSLSFNLHSHQRV | 466 | Q14590 | |
| NANHPFLFFIRHNKT | 371 | P48595 | |
| SFSQKSSLIQHQRFH | 416 | B7Z6K7 | |
| AFFQMLSLFRHQRTH | 371 | Q9Y473 | |
| LKSNFVHLFVSTLHF | 131 | O14657 | |
| THHINALIFFFIVSN | 321 | O76024 | |
| FSKLLSFHSLFTQHQ | 251 | Q8NB42 | |
| FNNSSNFRKHQRTHF | 261 | Q8NCA9 |